Studies have indicated that during the active phase of IBD development, the expression of CCL20 mRNA increases several-fold owing to the activation of TRL-1 and TRL-3 signals, facilitating the transfer of IL-17 from the blood to the intestine (36). Here, IL17A is linked to inflammatory bowel disease.